25 XP   0   0   10

Xenetic Biosciences Inc
Buy, Hold or Sell?

Let's analyse Xenetic Biosciences Inc together

PenkeI guess you are interested in Xenetic Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Xenetic Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Xenetic Biosciences Inc

I send you an email if I find something interesting about Xenetic Biosciences Inc.

Quick analysis of Xenetic Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Xenetic Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$6.36
Expected worth in 1 year
$3.86
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$-2.50
Return On Investment
-60.4%

For what price can you sell your share?

Current Price per Share
$4.14
Expected price per share
$3.55 - $6
How sure are you?
50%

1. Valuation of Xenetic Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

$4.14

Intrinsic Value Per Share

$-43.14 - $-23.20

Total Value Per Share

$-36.78 - $-16.84

2. Growth of Xenetic Biosciences Inc (5 min.)




Is Xenetic Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$9.7m$15m-$3.7m-32.7%

How much money is Xenetic Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1m-$1.5m$562.4k55.2%
Net Profit Margin-160.0%-374.4%--

How much money comes from the company's main activities?

3. Financial Health of Xenetic Biosciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#687 / 1016

Most Revenue
#534 / 1016

Most Profit
#240 / 1016

Most Efficient
#618 / 1016

What can you expect buying and holding a share of Xenetic Biosciences Inc? (5 min.)

Welcome investor! Xenetic Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Xenetic Biosciences Inc.

What can you expect buying and holding a share of Xenetic Biosciences Inc?

First you should know what it really means to hold a share of Xenetic Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Xenetic Biosciences Inc is $4.14. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Xenetic Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Xenetic Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $6.36. Based on the TTM, the Book Value Change Per Share is $-0.62 per quarter. Based on the YOY, the Book Value Change Per Share is $1.76 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Xenetic Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.76-18.4%-0.67-16.2%-0.26-6.3%-1.20-28.9%-3.34-80.6%
Usd Book Value Change Per Share-0.71-17.2%-0.62-15.1%1.7642.6%0.00-0.1%0.163.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.71-17.2%-0.62-15.1%1.7642.6%0.00-0.1%0.163.9%
Usd Price Per Share3.45-3.01-0.66-2.14-2.07-
Price to Earnings Ratio-1.13--1.08--1.43--1.17--0.70-
Price-to-Total Gains Ratio-4.85--4.61--3.62--2.57--3.50-
Price to Book Ratio0.54-0.43-0.53-0.48-0.40-
Price-to-Total Gains Ratio-4.85--4.61--3.62--2.57--3.50-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.14
Number of shares241
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.620.00
Usd Total Gains Per Share-0.620.00
Gains per Quarter (241 shares)-150.62-0.92
Gains per Year (241 shares)-602.47-3.66
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-602-6120-4-14
20-1205-12140-7-18
30-1807-18160-11-22
40-2410-24180-15-26
50-3012-30200-18-30
60-3615-36220-22-34
70-4217-42240-26-38
80-4820-48260-29-42
90-5422-54280-33-46
100-6025-60300-37-50

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%2.048.00.04.0%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%6.014.00.030.0%11.028.01.027.5%12.035.03.024.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.050.00.0%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%6.014.00.030.0%11.028.01.027.5%12.035.03.024.0%

Fundamentals of Xenetic Biosciences Inc

About Xenetic Biosciences Inc

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-12 22:38:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Xenetic Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Xenetic Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Xenetic Biosciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -174.3% means that $-1.74 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Xenetic Biosciences Inc:

  • The MRQ is -174.3%. The company is making a huge loss. -2
  • The TTM is -160.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-174.3%TTM-160.0%-14.3%
TTM-160.0%YOY-374.4%+214.4%
TTM-160.0%5Y-1,063.1%+903.0%
5Y-1,063.1%10Y-597.3%-465.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-174.3%-197.2%+22.9%
TTM-160.0%-210.4%+50.4%
YOY-374.4%-279.3%-95.1%
5Y-1,063.1%-436.8%-626.3%
10Y-597.3%-599.3%+2.0%
1.1.2. Return on Assets

Shows how efficient Xenetic Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Xenetic Biosciences Inc to the Biotechnology industry mean.
  • -11.0% Return on Assets means that Xenetic Biosciences Inc generated $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Xenetic Biosciences Inc:

  • The MRQ is -11.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.0%TTM-8.5%-2.6%
TTM-8.5%YOY-9.7%+1.2%
TTM-8.5%5Y-13.9%+5.4%
5Y-13.9%10Y-22.9%+9.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.0%-13.6%+2.6%
TTM-8.5%-12.9%+4.4%
YOY-9.7%-11.9%+2.2%
5Y-13.9%-14.2%+0.3%
10Y-22.9%-16.2%-6.7%
1.1.3. Return on Equity

Shows how efficient Xenetic Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Xenetic Biosciences Inc to the Biotechnology industry mean.
  • -12.0% Return on Equity means Xenetic Biosciences Inc generated $-0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Xenetic Biosciences Inc:

  • The MRQ is -12.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -9.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.0%TTM-9.2%-2.8%
TTM-9.2%YOY-10.5%+1.3%
TTM-9.2%5Y-15.9%+6.7%
5Y-15.9%10Y-39.8%+23.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.0%-17.0%+5.0%
TTM-9.2%-16.1%+6.9%
YOY-10.5%-15.4%+4.9%
5Y-15.9%-20.0%+4.1%
10Y-39.8%-21.1%-18.7%

1.2. Operating Efficiency of Xenetic Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Xenetic Biosciences Inc is operating .

  • Measures how much profit Xenetic Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Xenetic Biosciences Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Xenetic Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-84.4%+84.4%
TTM-84.4%YOY-395.3%+310.9%
TTM-84.4%5Y-409.0%+324.6%
5Y-409.0%10Y-269.6%-139.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.1%+286.1%
TTM-84.4%-224.4%+140.0%
YOY-395.3%-288.4%-106.9%
5Y-409.0%-475.2%+66.2%
10Y-269.6%-624.7%+355.1%
1.2.2. Operating Ratio

Measures how efficient Xenetic Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.87 means that the operating costs are $2.87 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Xenetic Biosciences Inc:

  • The MRQ is 2.869. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.774. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.869TTM2.774+0.095
TTM2.774YOY4.978-2.204
TTM2.7745Y9.117-6.343
5Y9.11710Y5.310+3.807
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8692.997-0.128
TTM2.7743.247-0.473
YOY4.9783.766+1.212
5Y9.1175.675+3.442
10Y5.3107.857-2.547

1.3. Liquidity of Xenetic Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Xenetic Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 11.84 means the company has $11.84 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Xenetic Biosciences Inc:

  • The MRQ is 11.842. The company is very able to pay all its short-term debts. +2
  • The TTM is 12.808. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.842TTM12.808-0.966
TTM12.808YOY13.527-0.719
TTM12.8085Y11.071+1.737
5Y11.07110Y6.428+4.642
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.8423.930+7.912
TTM12.8084.251+8.557
YOY13.5275.436+8.091
5Y11.0716.045+5.026
10Y6.4286.363+0.065
1.3.2. Quick Ratio

Measures if Xenetic Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Xenetic Biosciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 11.10 means the company can pay off $11.10 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Xenetic Biosciences Inc:

  • The MRQ is 11.096. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 11.640. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.096TTM11.640-0.545
TTM11.640YOY13.062-1.421
TTM11.6405Y10.353+1.287
5Y10.35310Y5.952+4.401
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.0963.629+7.467
TTM11.6404.065+7.575
YOY13.0625.397+7.665
5Y10.3535.993+4.360
10Y5.9526.277-0.325

1.4. Solvency of Xenetic Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Xenetic Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Xenetic Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.08 means that Xenetic Biosciences Inc assets are financed with 7.6% credit (debt) and the remaining percentage (100% - 7.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Xenetic Biosciences Inc:

  • The MRQ is 0.076. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.074. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.076TTM0.074+0.002
TTM0.074YOY0.069+0.005
TTM0.0745Y0.123-0.049
5Y0.12310Y0.249-0.126
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0760.332-0.256
TTM0.0740.334-0.260
YOY0.0690.268-0.199
5Y0.1230.366-0.243
10Y0.2490.390-0.141
1.4.2. Debt to Equity Ratio

Measures if Xenetic Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Xenetic Biosciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 8.3% means that company has $0.08 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Xenetic Biosciences Inc:

  • The MRQ is 0.083. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.080. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.083TTM0.080+0.002
TTM0.080YOY0.075+0.006
TTM0.0805Y0.153-0.073
5Y0.15310Y0.448-0.295
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0830.381-0.298
TTM0.0800.390-0.310
YOY0.0750.334-0.259
5Y0.1530.434-0.281
10Y0.4480.466-0.018

2. Market Valuation of Xenetic Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Xenetic Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Xenetic Biosciences Inc to the Biotechnology industry mean.
  • A PE ratio of -1.13 means the investor is paying $-1.13 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Xenetic Biosciences Inc:

  • The EOD is -1.361. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.134. Based on the earnings, the company is expensive. -2
  • The TTM is -1.077. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.361MRQ-1.134-0.227
MRQ-1.134TTM-1.077-0.058
TTM-1.077YOY-1.425+0.348
TTM-1.0775Y-1.169+0.092
5Y-1.16910Y-0.699-0.469
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.361-2.315+0.954
MRQ-1.134-2.560+1.426
TTM-1.077-2.664+1.587
YOY-1.425-4.122+2.697
5Y-1.169-6.258+5.089
10Y-0.699-6.108+5.409
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Xenetic Biosciences Inc:

  • The EOD is -2.011. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.676. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.200. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.011MRQ-1.676-0.335
MRQ-1.676TTM-1.200-0.476
TTM-1.200YOY-1.859+0.659
TTM-1.2005Y-1.437+0.237
5Y-1.43710Y-0.756-0.680
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.011-3.067+1.056
MRQ-1.676-3.251+1.575
TTM-1.200-3.545+2.345
YOY-1.859-5.595+3.736
5Y-1.437-8.315+6.878
10Y-0.756-8.708+7.952
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Xenetic Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.54 means the investor is paying $0.54 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Xenetic Biosciences Inc:

  • The EOD is 0.651. Based on the equity, the company is cheap. +2
  • The MRQ is 0.543. Based on the equity, the company is cheap. +2
  • The TTM is 0.427. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.651MRQ0.543+0.109
MRQ0.543TTM0.427+0.115
TTM0.427YOY0.528-0.101
TTM0.4275Y0.484-0.056
5Y0.48410Y0.398+0.086
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.6511.905-1.254
MRQ0.5432.111-1.568
TTM0.4272.095-1.668
YOY0.5282.836-2.308
5Y0.4843.443-2.959
10Y0.3983.794-3.396
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Xenetic Biosciences Inc.

3.1. Institutions holding Xenetic Biosciences Inc

Institutions are holding 1.099% of the shares of Xenetic Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Geode Capital Management, LLC0.713801099800
2023-12-31JTC Employer Solutions Trustee Ltd0.17520.0009270000
2023-12-31Steward Partners Investment Advisory, LLC0.12330.0001190000
2023-12-31Tower Research Capital LLC0.066201020-364-26.3006
2023-12-31UBS Group AG0.019803053050
2023-12-31Wells Fargo & Co0.0007011110
2023-12-31Morgan Stanley - Brokerage Accounts0.000101-294-99.661
2023-09-30Renaissance Technologies Corp000-25782-100
2023-09-30Royal Bank of Canada000-5300-100
2023-12-31FMR Inc000-1-100
2023-09-30NewSquare Capital, LLC000-26-100
Total 1.09910.00116935-31461-185.8%

3.2. Funds holding Xenetic Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.63590979700
2024-02-29Fidelity Extended Market Index0.51860.00017990-39-0.4857
2024-02-29Fidelity Nasdaq Composite Index0.13440.0001207000
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.06590.0001101600
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0530.000181620.2457
2023-12-31NT Ext Equity Mkt Idx Fd - L0.04940.000176100
2023-12-31Northern Trust Extended Eq Market Idx0.0494076100
2024-02-29Fidelity Series Total Market Index0.0463071400
2024-03-31State St US Extended Mkt Indx NL Cl C0.02530.000139000
2023-12-31SSgA U.S. Extended Market Index Class I0.02530.000139000
2024-02-29Spartan Total Market Index Pool E0.0108016600
2023-12-31SSgA U.S. Total Market Index Strategy0.00730112-3-2.6087
2024-02-29Spartan Extended Market Index Pool E0.0025039390
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00210.00013300
2024-02-29Fidelity U.S. Equity Index Ins Trust0.0012019190
Total 1.62740.000825074+18+0.1%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Xenetic Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.712-0.625-12%1.762-140%-0.004-99%0.163-536%
Book Value Per Share--6.3587.371-14%3.053+108%6.300+1%6.730-6%
Current Ratio--11.84212.808-8%13.527-12%11.071+7%6.428+84%
Debt To Asset Ratio--0.0760.074+3%0.069+10%0.123-38%0.249-69%
Debt To Equity Ratio--0.0830.080+3%0.075+11%0.153-46%0.448-82%
Dividend Per Share----0%-0%-0%-0%
Eps---0.760-0.671-12%-0.262-66%-1.198+58%-3.336+339%
Free Cash Flow Per Share---0.515-0.668+30%-0.192-63%-0.565+10%-0.806+57%
Free Cash Flow To Equity Per Share---0.515-0.668+30%0.032-1721%1.362-138%1.104-147%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---23.197--------
Intrinsic Value_10Y_min---43.140--------
Intrinsic Value_1Y_max---1.968--------
Intrinsic Value_1Y_min---3.432--------
Intrinsic Value_3Y_max---6.184--------
Intrinsic Value_3Y_min---11.143--------
Intrinsic Value_5Y_max---10.728--------
Intrinsic Value_5Y_min---19.709--------
Market Cap6378415.200+17%5315500.0684635366.882+15%8276570.337-36%6375391.338-17%4730648.172+12%
Net Profit Margin---1.743-1.600-8%-3.744+115%-10.631+510%-5.973+243%
Operating Margin----0.8440%-3.9530%-4.0900%-2.6960%
Operating Ratio--2.8692.774+3%4.978-42%9.117-69%5.310-46%
Pb Ratio0.651+17%0.5430.427+27%0.528+3%0.484+12%0.398+36%
Pe Ratio-1.361-20%-1.134-1.077-5%-1.425+26%-1.169+3%-0.699-38%
Price Per Share4.140+17%3.4503.009+15%0.661+422%2.139+61%2.071+67%
Price To Free Cash Flow Ratio-2.011-20%-1.676-1.200-28%-1.859+11%-1.437-14%-0.756-55%
Price To Total Gains Ratio-5.815-20%-4.846-4.612-5%-3.624-25%-2.573-47%-3.502-28%
Quick Ratio--11.09611.640-5%13.062-15%10.353+7%5.952+86%
Return On Assets---0.110-0.085-23%-0.097-12%-0.139+26%-0.229+107%
Return On Equity---0.120-0.092-23%-0.105-12%-0.159+33%-0.398+233%
Total Gains Per Share---0.712-0.625-12%1.762-140%-0.004-99%0.163-536%
Usd Book Value--9795641.00011356375.000-14%15069641.000-35%13710973.850-29%12371758.300-21%
Usd Book Value Change Per Share---0.712-0.625-12%1.762-140%-0.004-99%0.163-536%
Usd Book Value Per Share--6.3587.371-14%3.053+108%6.300+1%6.730-6%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.760-0.671-12%-0.262-66%-1.198+58%-3.336+339%
Usd Free Cash Flow---793027.000-1028554.750+30%-1161691.250+46%-1208282.400+52%-1409960.900+78%
Usd Free Cash Flow Per Share---0.515-0.668+30%-0.192-63%-0.565+10%-0.806+57%
Usd Free Cash Flow To Equity Per Share---0.515-0.668+30%0.032-1721%1.362-138%1.104-147%
Usd Market Cap6378415.200+17%5315500.0684635366.882+15%8276570.337-36%6375391.338-17%4730648.172+12%
Usd Price Per Share4.140+17%3.4503.009+15%0.661+422%2.139+61%2.071+67%
Usd Profit---1171506.000-1018989.250-13%-1581460.250+35%-1985773.400+70%-3337587.500+185%
Usd Revenue--671963.000634996.500+6%426731.250+57%293080.550+129%598665.275+12%
Usd Total Gains Per Share---0.712-0.625-12%1.762-140%-0.004-99%0.163-536%
 EOD+5 -3MRQTTM+11 -21YOY+8 -245Y+19 -1310Y+20 -12

4.2. Fundamental Score

Let's check the fundamental score of Xenetic Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.361
Price to Book Ratio (EOD)Between0-10.651
Net Profit Margin (MRQ)Greater than0-1.743
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than111.096
Current Ratio (MRQ)Greater than111.842
Debt to Asset Ratio (MRQ)Less than10.076
Debt to Equity Ratio (MRQ)Less than10.083
Return on Equity (MRQ)Greater than0.15-0.120
Return on Assets (MRQ)Greater than0.05-0.110
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Xenetic Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.496
Ma 20Greater thanMa 504.227
Ma 50Greater thanMa 1004.081
Ma 100Greater thanMa 2003.827
OpenGreater thanClose3.920
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets10,605
Total Liabilities810
Total Stockholder Equity9,796
 As reported
Total Liabilities 810
Total Stockholder Equity+ 9,796
Total Assets = 10,605

Assets

Total Assets10,605
Total Current Assets9,587
Long-term Assets1,018
Total Current Assets
Cash And Cash Equivalents 8,983
Other Current Assets 604
Total Current Assets  (as reported)9,587
Total Current Assets  (calculated)9,587
+/-0
Long-term Assets
Long-term Assets Other 1,018
Long-term Assets  (as reported)1,018
Long-term Assets  (calculated)1,018
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities810
Long-term Liabilities0
Total Stockholder Equity9,796
Total Current Liabilities
Accounts payable 241
Other Current Liabilities 569
Total Current Liabilities  (as reported)810
Total Current Liabilities  (calculated)810
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock2
Retained Earnings -193,234
Accumulated Other Comprehensive Income 254
Other Stockholders Equity 202,773
Total Stockholder Equity (as reported)9,796
Total Stockholder Equity (calculated)9,794
+/- 2
Other
Capital Stock3
Cash and Short Term Investments 8,983
Common Stock Shares Outstanding 1,537
Liabilities and Stockholders Equity 10,605
Net Debt -8,983
Net Invested Capital 9,794
Net Working Capital 8,777



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-30
> Total Assets 
0
251
251
304
324
352
271
277
487
449
25,868
23,053
19,318
16,316
16,316
13,270
14,254
16,908
18,360
13,161
13,866
20,974
18,832
16,438
14,640
19,164
17,543
17,257
15,534
14,431
16,456
15,633
22,875
21,547
20,625
19,063
8,696
13,179
11,762
10,915
21,285
19,815
17,984
16,468
15,573
14,720
13,716
12,749
11,961
10,605
10,60511,96112,74913,71614,72015,57316,46817,98419,81521,28510,91511,76213,1798,69619,06320,62521,54722,87515,63316,45614,43115,53417,25717,54319,16414,64016,43818,83220,97413,86613,16118,36016,90814,25413,27016,31616,31619,31823,05325,8684494872772713523243042512510
   > Total Current Assets 
0
47
47
106
131
164
88
100
73
53
11,499
8,287
5,358
2,777
2,777
498
1,507
4,191
5,653
478
1,209
8,339
6,210
3,831
2,049
5,885
4,276
4,000
2,289
1,194
3,201
2,389
12,921
11,090
10,678
9,116
7,992
12,370
11,036
10,199
20,581
18,723
16,889
15,376
14,167
13,653
12,871
12,045
11,257
9,587
9,58711,25712,04512,87113,65314,16715,37616,88918,72320,58110,19911,03612,3707,9929,11610,67811,09012,9212,3893,2011,1942,2894,0004,2765,8852,0493,8316,2108,3391,2094785,6534,1911,5074982,7772,7775,3588,28711,49953731008816413110647470
       Cash And Cash Equivalents 
0
11
11
33
32
32
45
62
53
40
10,858
7,614
4,835
2,507
2,507
301
1,246
132
1,606
241
212
4,048
4,324
2,332
695
5,533
3,866
3,258
1,612
572
2,018
1,034
12,044
10,368
9,367
8,066
7,054
11,528
10,008
9,282
19,703
18,244
16,156
14,927
13,848
13,097
11,995
10,726
9,776
8,983
8,9839,77610,72611,99513,09713,84814,92716,15618,24419,7039,28210,00811,5287,0548,0669,36710,36812,0441,0342,0185721,6123,2583,8665,5336952,3324,3244,0482122411,6061321,2463012,5072,5074,8357,61410,8584053624532323311110
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
66
66
66
66
66
66
66
67
67
67
67
67
66
66
67
67
67
67
67
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000676767676766666767676767666666666666660000000000
       Net Receivables 
0
36
36
72
99
132
43
29
11
5
246
183
218
116
116
2
0
0
0
0
0
3,000
3,000
0
43
0
0
0
0
0
0
0
0
0
0
0
0
500
500
500
400
0
0
0
0
0
0
0
0
0
0000000004005005005000000000000004303,0003,0000000021161162181832465112943132997236360
       Other Current Assets 
0
0
0
0
0
0
9
9
9
9
395
490
305
88
154
195
261
4,058
4,047
238
997
1,291
1,887
1,499
1,312
352
410
742
677
622
1,183
1,355
877
722
1,310
1,049
938
842
1,028
918
878
479
732
449
319
556
877
1,319
1,481
604
6041,4811,3198775563194497324798789181,0288429381,0491,3107228771,3551,1836226777424103521,3121,4991,8871,2919972384,0474,058261195154883054903959999000000
   > Long-term Assets 
0
204
204
198
193
188
182
177
414
396
14,369
14,766
13,960
13,539
13,539
12,771
12,747
12,718
12,707
12,682
12,657
12,635
12,621
12,607
12,591
13,279
13,267
13,257
13,245
13,237
13,255
13,244
9,954
10,457
9,948
9,948
704
810
726
716
704
1,092
1,095
1,092
1,406
1,067
844
704
704
1,018
1,0187047048441,0671,4061,0921,0951,0927047167268107049,9489,94810,4579,95413,24413,25513,23713,24513,25713,26713,27912,59112,60712,62112,63512,65712,68212,70712,71812,74712,77113,53913,53913,96014,76614,3693964141771821881931982042040
       Property Plant Equipment 
0
204
204
198
193
188
182
177
414
396
149
156
137
119
119
83
74
62
68
58
49
42
40
38
32
28
22
16
8
5
3
3
2
1
0
0
0
27
18
8
0
0
0
0
0
0
0
0
0
0
000000000081827000123358162228323840424958686274831191191371561493964141771821881931982042040
       Goodwill 
0
0
0
0
0
0
0
0
0
3,670
3,698
3,802
3,597
3,465
3,465
3,283
3,283
3,283
3,283
3,283
3,283
3,283
3,283
3,283
3,283
3,283
3,283
3,283
3,283
3,283
3,283
3,283
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000003,2833,2833,2833,2833,2833,2833,2833,2833,2833,2833,2833,2833,2833,2833,2833,2833,2833,4653,4653,5973,8023,6983,670000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
10,320
10,410
10,702
10,127
9,755
9,755
9,243
9,243
9,243
9,243
9,243
9,243
9,243
9,243
9,243
9,243
9,243
9,243
9,243
9,243
9,243
9,243
9,243
9,243
9,243
9,243
9,243
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000009,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,7559,75510,12710,70210,41010,320000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
14,220
14,610
13,823
13,420
12,780
12,689
12,673
12,655
12,639
12,624
12,607
12,593
12,582
12,569
12,559
13,251
718
714
710
706
685
682
709
1,213
704
704
704
810
726
716
704
1,092
1,095
1,092
1,406
0
0
704
0
0
00704001,4061,0921,0951,0927047167268107047047041,21370968268570671071471813,25112,55912,56912,58212,59312,60712,62412,63912,65512,67312,68912,78013,42013,82314,61014,2200000000000
> Total Liabilities 
0
297
297
353
417
459
363
383
669
714
6,057
5,559
5,303
5,835
5,835
6,435
9,071
10,300
13,299
6,748
7,912
4,804
4,928
4,930
5,085
4,862
4,658
4,473
4,238
4,518
4,938
5,242
4,616
4,334
4,426
3,706
788
964
816
966
1,121
1,421
1,063
1,279
1,051
1,073
856
871
1,068
810
8101,0688718561,0731,0511,2791,0631,4211,1219668169647883,7064,4264,3344,6165,2424,9384,5184,2384,4734,6584,8625,0854,9304,9284,8047,9126,74813,29910,3009,0716,4355,8355,8355,3035,5596,0577146693833634594173532972970
   > Total Current Liabilities 
0
84
84
141
204
246
150
171
456
341
2,700
2,115
2,044
2,699
2,699
3,469
6,109
7,342
10,347
3,801
4,969
1,866
1,994
2,001
2,161
1,944
1,739
1,554
1,320
1,600
2,006
2,318
1,697
1,415
1,507
787
788
937
798
958
1,121
1,421
1,063
1,279
1,051
1,073
856
871
1,068
810
8101,0688718561,0731,0511,2791,0631,4211,1219587989377887871,5071,4151,6972,3182,0061,6001,3201,5541,7391,9442,1612,0011,9941,8664,9693,80110,3477,3426,1093,4692,6992,6992,0442,1152,70034145617115024620414184840
       Short-term Debt 
0
0
0
0
0
0
0
0
0
680
0
0
0
395
395
395
395
395
158
153
153
0
0
0
0
0
0
0
0
0
26
0
0
0
0
0
0
0
0
0
0
0
0
10
0
0
0
0
0
0
0000001000000000000026000000000153153158395395395395395000680000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
395
0
0
0
4,048
0
0
0
0
0
0
0
0
0
0
0
0
26
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000260000000000004,0480003950000000000000
       Accounts payable 
0
77
77
130
191
230
130
147
430
309
592
590
761
2,657
853
1,757
1,485
1,789
1,630
2,021
2,172
1,007
1,369
1,013
1,027
787
896
747
513
934
1,040
1,024
1,159
931
1,051
250
251
327
208
305
248
362
281
473
203
287
259
221
449
241
2414492212592872034732813622483052083272512501,0519311,1591,0241,0409345137478967871,0271,0131,3691,0072,1722,0211,6301,7891,4851,7578532,65776159059230943014713023019113077770
       Other Current Liabilities 
0
7
7
10
14
17
20
23
26
32
2,107
1,525
1,283
41
1,846
455
2,848
3,672
7,022
20
1,155
859
626
920
1,113
1,157
843
808
807
666
966
1,294
539
484
456
537
537
610
590
653
873
1,059
783
806
848
786
597
650
620
569
5696206505977868488067831,0598736535906105375374564845391,2949666668078088431,1571,1139206268591,155207,0223,6722,8484551,846411,2831,5252,10732262320171410770
   > Long-term Liabilities 
0
213
213
213
213
213
213
213
213
373
3,358
3,444
3,258
3,136
3,136
2,966
2,962
2,957
2,953
2,948
2,943
2,938
2,934
2,929
2,923
2,919
2,919
2,919
2,919
2,919
2,932
2,925
2,919
2,919
2,919
2,919
251
27
18
8
248
362
281
473
203
287
259
0
0
0
000259287203473281362248818272512,9192,9192,9192,9192,9252,9322,9192,9192,9192,9192,9192,9232,9292,9342,9382,9432,9482,9532,9572,9622,9663,1363,1363,2583,4443,3583732132132132132132132132130
       Long term Debt Total 
0
0
0
0
0
0
0
0
373
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000037300000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
70
65
61
56
52
47
43
38
33
29
24
20
15
10
5
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
0
27
18
8
0
0
0
0
0
0
0
0
0
0
00000000008182702,9192,9192,9192,9192,9192,9192,9192,9192,9192,9192,919510152024293338434752566165700000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
3,258
3,287
3,379
3,198
3,080
2,936
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
2,919
0
27
0
0
0
0
0
0
0
0
0
0
0
0
0000000000002702,9192,9192,9192,9192,9192,9192,9192,9192,9192,9192,9192,9192,9192,9192,9192,9192,9192,9192,9192,9192,9192,9363,0803,1983,3793,2873,258000000000
> Total Stockholder Equity
0
-46
-46
-50
-93
-107
-92
-106
-182
-265
19,811
17,493
14,015
10,481
10,481
6,835
5,183
6,609
5,061
6,412
5,954
16,169
13,904
11,509
9,555
14,301
12,885
12,785
11,296
9,913
11,519
10,391
18,259
17,213
16,199
15,358
7,908
12,216
10,946
9,949
20,164
18,394
16,920
15,189
14,522
13,647
12,859
11,878
10,893
9,796
9,79610,89311,87812,85913,64714,52215,18916,92018,39420,1649,94910,94612,2167,90815,35816,19917,21318,25910,39111,5199,91311,29612,78512,88514,3019,55511,50913,90416,1695,9546,4125,0616,6095,1836,83510,48110,48114,01517,49319,811-265-182-106-92-107-93-50-46-460
   Common Stock
0
10
10
14
14
14
135
135
135
135
1,467
1,467
1,467
1,500
1,500
1,500
151
162
163
9
9
9
9
9
9
9
10
10
10
10
11
1
6
6
6
6
6
9
9
9
13
13
13
14
14
15
15
2
2
2
22215151414131313999666661111010101099999991631621511,5001,5001,5001,4671,4671,46713513513513514141410100
   Retained Earnings Total Equity000-189,956000000-179,355-178,248-176,902-175,702-168,142-167,188-166,009-164,838-155,938-154,561-153,234-151,594-149,782-147,756-145,933-150,378-148,123-145,204-142,338-141,947-139,475-91,704-88,132-84,505-79,181-78,056-75,624-71,321-68,139-65,380-58,307-40000000000
   Accumulated Other Comprehensive Income 
0
-9
-14
-14
-25
-25
-30
-35
-58
1,000
1,026
1,424
882
1,000
576
249
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
254
2542542542542542542542542542542542542542542542542542542542542542542542542542542542542542542542542542542495761,0008821,4241,0261,000-58-35-30-25-25-14-14-90
   Capital Surplus 
0
0
0
0
0
0
0
0
0
74,000
87,979
88,022
88,269
89,311
89,458
89,548
94,564
99,606
101,629
150,905
152,865
163,523
164,123
164,647
164,949
165,250
165,656
167,581
167,905
168,161
171,093
171,353
188,117
188,240
188,406
188,518
188,628
194,134
194,210
194,320
0
0
0
0
0
0
207,825
0
0
0
000207,825000000194,320194,210194,134188,628188,518188,406188,240188,117171,353171,093168,161167,905167,581165,656165,250164,949164,647164,123163,523152,865150,905101,62999,60694,56489,54889,45889,31188,26988,02287,97974,000000000000
   Treasury Stock0000000000-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281-5,281000000000
   Other Stockholders Equity 
0
0
32
32
32
32
0
0
0
900
82,698
82,741
82,987
576
84,030
84,267
89,283
94,325
96,348
145,624
147,637
158,242
158,842
159,366
159,667
159,969
160,375
162,300
162,624
162,880
165,812
166,072
182,836
182,959
183,125
183,236
183,347
188,852
188,929
189,039
200,600
200,672
200,791
201,731
201,869
202,475
202,544
202,627
202,697
202,773
202,773202,697202,627202,544202,475201,869201,731200,791200,672200,600189,039188,929188,852183,347183,236183,125182,959182,836166,072165,812162,880162,624162,300160,375159,969159,667159,366158,842158,242147,637145,62496,34894,32589,28384,26784,03057682,98782,74182,6989000003232323200



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,540
Cost of Revenue-0
Gross Profit2,5402,540
 
Operating Income (+$)
Gross Profit2,540
Operating Expense-7,056
Operating Income-4,516-4,516
 
Operating Expense (+$)
Research Development3,495
Selling General Administrative3,561
Selling And Marketing Expenses0
Operating Expense7,0567,056
 
Net Interest Income (+$)
Interest Income352
Interest Expense-0
Other Finance Cost-0
Net Interest Income352
 
Pretax Income (+$)
Operating Income-4,516
Net Interest Income352
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,135-4,897
EBIT - interestExpense = 0
-4,135
-4,135
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-4,135
Earnings Before Interest and Taxes (EBITDA)-4,516
 
After tax Income (+$)
Income Before Tax-4,135
Tax Provision-0
Net Income From Continuing Ops-4,446-4,135
Net Income-4,135
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses7,056
Total Other Income/Expenses Net381-352
 

Technical Analysis of Xenetic Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Xenetic Biosciences Inc. The general trend of Xenetic Biosciences Inc is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Xenetic Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Xenetic Biosciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.74 < 5.97 < 6.

The bearish price targets are: 3.65 > 3.55 > 3.55.

Tweet this
Xenetic Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Xenetic Biosciences Inc. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Xenetic Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Xenetic Biosciences Inc. The current macd is 0.0229526.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Xenetic Biosciences Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Xenetic Biosciences Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Xenetic Biosciences Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Xenetic Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartXenetic Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Xenetic Biosciences Inc. The current adx is 13.61.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Xenetic Biosciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Xenetic Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Xenetic Biosciences Inc. The current sar is 4.63838776.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Xenetic Biosciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Xenetic Biosciences Inc. The current rsi is 48.50. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Xenetic Biosciences Inc Daily Relative Strength Index (RSI) ChartXenetic Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Xenetic Biosciences Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Xenetic Biosciences Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Xenetic Biosciences Inc Daily Stochastic Oscillator ChartXenetic Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Xenetic Biosciences Inc. The current cci is -19.81983758.

Xenetic Biosciences Inc Daily Commodity Channel Index (CCI) ChartXenetic Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Xenetic Biosciences Inc. The current cmo is -7.21969906.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Xenetic Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartXenetic Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Xenetic Biosciences Inc. The current willr is -64.23982869.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Xenetic Biosciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Xenetic Biosciences Inc Daily Williams %R ChartXenetic Biosciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Xenetic Biosciences Inc.

Xenetic Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Xenetic Biosciences Inc. The current atr is 0.28472833.

Xenetic Biosciences Inc Daily Average True Range (ATR) ChartXenetic Biosciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Xenetic Biosciences Inc. The current obv is 695,209.

Xenetic Biosciences Inc Daily On-Balance Volume (OBV) ChartXenetic Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Xenetic Biosciences Inc. The current mfi is 75.31.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Xenetic Biosciences Inc Daily Money Flow Index (MFI) ChartXenetic Biosciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Xenetic Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Xenetic Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Xenetic Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.496
Ma 20Greater thanMa 504.227
Ma 50Greater thanMa 1004.081
Ma 100Greater thanMa 2003.827
OpenGreater thanClose3.920
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Xenetic Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Xenetic Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Xenetic Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Xenetic Biosciences Inc

I send you an email if I find something interesting about Xenetic Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Xenetic Biosciences Inc.

Receive notifications about Xenetic Biosciences Inc in your mailbox!